View in EDS HTML Full Text PDF Full Text

Repurposing of the Antiepileptic Drug Levetiracetam to Restrain Neuroendocrine Prostate Cancer and Inhibit Mast Cell Support to Adenocarcinoma.

Saved in:
Bibliographic Details
Title: Repurposing of the Antiepileptic Drug Levetiracetam to Restrain Neuroendocrine Prostate Cancer and Inhibit Mast Cell Support to Adenocarcinoma.
Authors: Sulsenti R; Molecular Immunology Unit, Department of Research, Fondazione Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori, Milan, Italy., Frossi B; Immunology Section, Department of Medicine, University of Udine, Udine, Italy., Bongiovanni L; Tumor Immunology Unit, Department of Health Sciences, University of Palermo, Palermo, Italy., Cancila V; Tumor Immunology Unit, Department of Health Sciences, University of Palermo, Palermo, Italy., Ostano P; Laboratory of Cancer Genomics, Fondazione Edo ed Elvo Tempia, Biella, Italy., Fischetti I; Molecular Immunology Unit, Department of Research, Fondazione Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori, Milan, Italy., Enriquez C; Molecular Immunology Unit, Department of Research, Fondazione Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori, Milan, Italy., Guana F; Laboratory of Cancer Genomics, Fondazione Edo ed Elvo Tempia, Biella, Italy., Chiorino G; Laboratory of Cancer Genomics, Fondazione Edo ed Elvo Tempia, Biella, Italy., Tripodo C; Tumor Immunology Unit, Department of Health Sciences, University of Palermo, Palermo, Italy., Pucillo CE; Immunology Section, Department of Medicine, University of Udine, Udine, Italy., Colombo MP; Molecular Immunology Unit, Department of Research, Fondazione Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori, Milan, Italy., Jachetti E; Molecular Immunology Unit, Department of Research, Fondazione Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori, Milan, Italy.
Source: Frontiers in immunology [Front Immunol] 2021 Mar 02; Vol. 12, pp. 622001. Date of Electronic Publication: 2021 Mar 02 (Print Publication: 2021).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33737929
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Repurposing of the Antiepileptic Drug Levetiracetam to Restrain Neuroendocrine Prostate Cancer and Inhibit Mast Cell Support to Adenocarcinoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Sulsenti+R%22">Sulsenti R</searchLink>; Molecular Immunology Unit, Department of Research, Fondazione Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Frossi+B%22">Frossi B</searchLink>; Immunology Section, Department of Medicine, University of Udine, Udine, Italy.<br /><searchLink fieldCode="AU" term="%22Bongiovanni+L%22">Bongiovanni L</searchLink>; Tumor Immunology Unit, Department of Health Sciences, University of Palermo, Palermo, Italy.<br /><searchLink fieldCode="AU" term="%22Cancila+V%22">Cancila V</searchLink>; Tumor Immunology Unit, Department of Health Sciences, University of Palermo, Palermo, Italy.<br /><searchLink fieldCode="AU" term="%22Ostano+P%22">Ostano P</searchLink>; Laboratory of Cancer Genomics, Fondazione Edo ed Elvo Tempia, Biella, Italy.<br /><searchLink fieldCode="AU" term="%22Fischetti+I%22">Fischetti I</searchLink>; Molecular Immunology Unit, Department of Research, Fondazione Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Enriquez+C%22">Enriquez C</searchLink>; Molecular Immunology Unit, Department of Research, Fondazione Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Guana+F%22">Guana F</searchLink>; Laboratory of Cancer Genomics, Fondazione Edo ed Elvo Tempia, Biella, Italy.<br /><searchLink fieldCode="AU" term="%22Chiorino+G%22">Chiorino G</searchLink>; Laboratory of Cancer Genomics, Fondazione Edo ed Elvo Tempia, Biella, Italy.<br /><searchLink fieldCode="AU" term="%22Tripodo+C%22">Tripodo C</searchLink>; Tumor Immunology Unit, Department of Health Sciences, University of Palermo, Palermo, Italy.<br /><searchLink fieldCode="AU" term="%22Pucillo+CE%22">Pucillo CE</searchLink>; Immunology Section, Department of Medicine, University of Udine, Udine, Italy.<br /><searchLink fieldCode="AU" term="%22Colombo+MP%22">Colombo MP</searchLink>; Molecular Immunology Unit, Department of Research, Fondazione Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Jachetti+E%22">Jachetti E</searchLink>; Molecular Immunology Unit, Department of Research, Fondazione Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori, Milan, Italy.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2021 Mar 02; Vol. 12, pp. 622001. <i>Date of Electronic Publication: </i>2021 Mar 02 (<i>Print Publication: </i>2021).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33737929
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2021.622001
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 622001
    Titles:
      – TitleFull: Repurposing of the Antiepileptic Drug Levetiracetam to Restrain Neuroendocrine Prostate Cancer and Inhibit Mast Cell Support to Adenocarcinoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Sulsenti R
      – PersonEntity:
          Name:
            NameFull: Frossi B
      – PersonEntity:
          Name:
            NameFull: Bongiovanni L
      – PersonEntity:
          Name:
            NameFull: Cancila V
      – PersonEntity:
          Name:
            NameFull: Ostano P
      – PersonEntity:
          Name:
            NameFull: Fischetti I
      – PersonEntity:
          Name:
            NameFull: Enriquez C
      – PersonEntity:
          Name:
            NameFull: Guana F
      – PersonEntity:
          Name:
            NameFull: Chiorino G
      – PersonEntity:
          Name:
            NameFull: Tripodo C
      – PersonEntity:
          Name:
            NameFull: Pucillo CE
      – PersonEntity:
          Name:
            NameFull: Colombo MP
      – PersonEntity:
          Name:
            NameFull: Jachetti E
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 03
              Text: 2021 Mar 02
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 12
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1